[AFFIN] YoY Cumulative Quarter Result on 30-Sep-2011 [#3]

Stock
[AFFIN] AFFIN BANK BERHAD
Announcement Date
18-Nov-2011
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2011
Quarter
30-Sep-2011 [#3]
Profit Trend
QoQ- 56.27%
YoY- 3.7%
Quarter Report
Latest QR
Upcoming QR
AFFIN's Result
AFFIN's Financial Summary
View:
Show?
Cumulative Result
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Revenue 1,338,760 2,253,973 2,215,532 1,953,601 1,652,451 1,498,449 1,602,863 -2.95%
PBT 520,029 634,819 621,330 534,474 480,831 383,158 288,640 10.30%
Tax -131,391 -151,713 -152,769 -159,022 -118,778 -95,485 -79,985 8.61%
NP 388,638 483,106 468,561 375,452 362,053 287,673 208,655 10.91%
-
NP to SH 384,067 483,106 468,561 375,452 362,053 287,673 208,655 10.69%
-
Tax Rate 25.27% 23.90% 24.59% 29.75% 24.70% 24.92% 27.71% -
Total Cost 950,122 1,770,867 1,746,971 1,578,149 1,290,398 1,210,776 1,394,208 -6.18%
-
Net Worth 7,713,310 6,487,252 6,053,180 5,589,930 5,170,051 4,722,320 4,376,228 9.90%
Dividend
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Div 289,249 224,213 224,191 179,356 134,481 127,024 74,679 25.30%
Div Payout % 75.31% 46.41% 47.85% 47.77% 37.14% 44.16% 35.79% -
Equity
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Net Worth 7,713,310 6,487,252 6,053,180 5,589,930 5,170,051 4,722,320 4,376,228 9.90%
NOSH 1,942,948 1,494,758 1,494,612 1,494,633 1,494,234 1,494,405 1,493,593 4.47%
Ratio Analysis
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
NP Margin 29.03% 21.43% 21.15% 19.22% 21.91% 19.20% 13.02% -
ROE 4.98% 7.45% 7.74% 6.72% 7.00% 6.09% 4.77% -
Per Share
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 69.43 150.79 148.23 130.71 110.59 100.27 107.32 -6.99%
EPS 23.41 32.32 31.35 25.12 24.23 19.25 13.97 8.98%
DPS 15.00 15.00 15.00 12.00 9.00 8.50 5.00 20.08%
NAPS 4.00 4.34 4.05 3.74 3.46 3.16 2.93 5.32%
Adjusted Per Share Value based on latest NOSH - 1,493,900
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
RPS 55.77 93.90 92.30 81.38 68.84 62.42 66.77 -2.95%
EPS 16.00 20.13 19.52 15.64 15.08 11.98 8.69 10.70%
DPS 12.05 9.34 9.34 7.47 5.60 5.29 3.11 25.31%
NAPS 3.2132 2.7025 2.5216 2.3287 2.1538 1.9672 1.8231 9.90%
Price Multiplier on Financial Quarter End Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 30/09/14 30/09/13 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 -
Price 3.40 4.39 3.37 2.49 3.12 1.95 1.60 -
P/RPS 4.90 2.91 2.27 1.91 2.82 1.94 1.49 21.93%
P/EPS 17.07 13.58 10.75 9.91 12.88 10.13 11.45 6.87%
EY 5.86 7.36 9.30 10.09 7.77 9.87 8.73 -6.42%
DY 4.41 3.42 4.45 4.82 2.88 4.36 3.13 5.87%
P/NAPS 0.85 1.01 0.83 0.67 0.90 0.62 0.55 7.52%
Price Multiplier on Announcement Date
30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 CAGR
Date 24/11/14 28/11/13 19/11/12 18/11/11 26/11/10 20/11/09 18/11/08 -
Price 3.05 4.22 3.37 2.90 3.17 2.38 1.27 -
P/RPS 4.39 2.80 2.27 2.22 2.87 2.37 1.18 24.46%
P/EPS 15.31 13.06 10.75 11.54 13.08 12.36 9.09 9.07%
EY 6.53 7.66 9.30 8.66 7.64 8.09 11.00 -8.32%
DY 4.92 3.55 4.45 4.14 2.84 3.57 3.94 3.76%
P/NAPS 0.76 0.97 0.83 0.78 0.92 0.75 0.43 9.95%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment